¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Y52"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y52
    Agents primarily affecting the cardiovascular system
    ÀÏÂ÷ÀûÀ¸·Î ½ÉÀåÇ÷°ü°èÅë¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦
  • Y52.4
    Angiotensin-converting-enzyme inhibitors
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¾à¹°
  • Y52.6
    Antihyperlipidaemic and antiarteriosclerotic drugs
    Ç×°íÁöÁúÇ÷Áõ ¹× Ç×µ¿¸Æ°æÈ­Áõ ¾à¹°
  • Y52.8
    Antivaricose drugs, including sclerosing agents
    Ç×Á¤¸Æ·ù¾àÁ¦, °æÈ­Á¦ Æ÷ÇÔ
  • Y52.1
    Calcium-channel blockers
    Ä®½· ä³Î Â÷´ÜÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á